C
Covant Therapeutics
Biotechnology📍 Boston, MA
Covant Therapeutics develops covalent small molecules targeting post-translational modification sites, focusing on FcRn inhibitors and ADAR1 for cancer immunotherapy.
Open Positions at Covant Therapeutics
0 positions available
No open positions at the moment
Check back later for new opportunities!